Gurbel, Paul A. http://orcid.org/0000-0002-5461-568X
Tantry, Udaya S.
Bliden, Kevin P.
Fisher, Richard
Sukavaneshvar, Sivaprasad
Dahlen, Jeffrey
Speros, Philip C.
Funding for this research was provided by:
Aggredyne, Inc, Houston, TX, USA
Article History
Accepted: 1 June 2021
First Online: 18 June 2021
Declarations
:
: Dr. Gurbel reports grants and personal fees from Bayer HealthCare LLC, Otitopic Inc, Amgen, Janssen, and US WorldMeds LLC; grants from Instrumentation Laboratory, Haemonetics, Medicure Inc, Idorsia Pharmaceuticals, and Hikari Dx; personal fees from UpToDate; Dr Gurbel is a relator and expert witness in litigation involving clopidogrel; in addition, Dr. Gurbel has two patents: Detection of restenosis risk in patients and Assessment of cardiac health and thrombotic risk in a patient. Dr. Tantry reports personal fees from UptoDate and Aggredyne. Richard Fisher is an employee of Aggredyne; Philip C Speros was an employee of Aggredyne and is an employee of PCS Houston; Sivaprasad Sukavaneshvar is an employee of Thrombodyne Inc. and Jeff Dahlen is an employee of Hikari Dx.